A pilot study of neurocognitive function in older and younger cocaine abusers and controls

American Journal on Addictions

Volumn 20, Issue 3, 2011, Pages 228-239

  Kalapatapu, Raj K ^a   Vadhan, Nehal P ^a   Rubin, Eric ^a   Bedi, Gillinder ^a   Cheng, Wendy Y ^a   Sullivan, Maria A ^a   Foltin, Richard W ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ADULT; AGED; AGING; ARTICLE; COGNITION; CONTROLLED STUDY; DIGIT SPAN BACKWARD; DRUG ABUSE; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL STRESS; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGY; OUTCOME ASSESSMENT; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC TEST; SCORING SYSTEM; SOCIAL STRESS; STRUCTURED INTERVIEW; TASK PERFORMANCE; TRAIL TRACKING TEST;

ADULT; AGED; AGING; ATTENTION; COCAINE-RELATED DISORDERS; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE;

EID: 79953883521     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2011.00128.x     Document Type: Article

References (58)

1. Dowling GJ, Weiss SR, Condon TP,. Drugs of abuse and the aging brain. Neuropsychopharmacology. 2008; 33: 209-218. (Pubitemid 350243353)
2. Armstrong GL,. Injection drug users in the United States,1979-2002: An aging population. Arch Intern Med. 2007; 167: 166-173. (Pubitemid 46148064)
3. The National Survey on Drug Use and Health Report. Illicit Drug Use among Older Adults. Rockville, MD: SAMHSA. 2009. Available at:. Accessed July 16, 2010.
4. Han B, Gfroerer JC, Colliver JD, Penne MA,. Substance use disorder among older adults in the United States in 2020. Addiction. 2009; 104: 88-96.
5. Research Report Series. Cocaine: Abuse and Addiction. Bethesda, MD: National Institute on Drug Abuse. NIH Publication Number 09-4166. May 2009. Available at:. Accessed July 16, 2010.
6. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS). Highlights-2005. National Admissions to Substance Abuse Treatment Services. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2006. DASIS Series: S-36, DHHS Publication No. (SMA) 07-4229. Available at:. Accessed July 16, 2010.
7. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS). Highlights-2006. National Admissions to Substance Abuse Treatment Services. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2008. DASIS Series: S-40, DHHS Publication No. (SMA) 08-4313. Available at:. Accessed July 16, 2010.
8. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS). Highlights-2007. National Admissions to Substance Abuse Treatment Services. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2009. DASIS Series: S-45, DHHS Publication No. (SMA) 09-4360. Available at:. Accessed July 16, 2010.
9. Kausch O,. Cocaine abuse in the elderly: A series of three case reports. J Nerv Ment Dis. 2002; 190: 562-565. (Pubitemid 34988630)
10. Nambudiri DE, Young RC,. A case of late-onset crack dependence and subsequent psychosis in the elderly. J Subst Abuse Treat. 1991; 8: 253-255.
11. Abrams RC, Alexopoulos GS,. Substance abuse in the elderly: Over-the-counter and illegal drugs. Hosp Community Psychiatry. 1988; 39: 822-823, 829.
12. Weintraub E, Weintraub D, Dixon L, et al,. Geriatric patients on a substance abuse consultation service. Am J Geriatr Psychiatry. 2002; 10: 337-342. (Pubitemid 34517689)
13. Rivers E, Shirazi E, Aurora T, et al,. Cocaine use in elder patients presenting to an inner-city emergency department. Acad Emerg Med. 2004; 11: 874-877. (Pubitemid 38951096)
14. Schonfeld L, Dupree LW, Dickson-Euhrmann E, et al,. Cognitive-behavioral treatment of older veterans with substance abuse problems. J Geriatr Psychiatry Neurol. 2000; 13: 124-129.
15. Caserta MT, Bannon Y, Fernandez F, et al,. Normal brain aging clinical, immunological, neuropsychological, and neuroimaging features. Int Rev Neurobiol. 2009; 84: 1-19.
16. Nakamura JE, Cohler BJ,. Self, morale, and the social world of older adults. In:, Sadavoy J, Jarvik LF, Grossberg GT, Meyers BS, eds. Comprehensive Textbook of Geriatric Psychiatry. New York, NY: W.W. Norton & Company; 2004: 159-202.
17. Fiori KL, Antonucci TC, Cortina KS,. Social network typologies and mental health among older adults. J Gerontol B Psychol Sci Soc Sci. 2006; 61: 25-32.
18. Der G, Deary IJ,. Age and sex differences in reaction time in adulthood: Results from the United Kingdom Health and Lifestyle Survey. Psychol Aging. 2006; 21: 62-73. (Pubitemid 44212047)
19. Salthouse TA,. The aging of working memory. Neuropsychology. 1994; 8: 535-543.
20. Bopp KL, Verhaeghen P,. Aging and verbal memory span: A meta-analysis. J Gerontol B Psychol Sci Soc Sci. 2005; 60: 223-233.
21. Keys BA, White DA,. Exploring the relationship between age, executive abilities, and psychomotor speed. J Int Neuropsychol Soc. 2000; 6: 76-82. (Pubitemid 30099195)
22. Beatty WW, Katzung VM, Moreland VJ, et al,. Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug Alcohol Depend. 1995; 37: 247-253.
23. Ardila A, Rosselli M, Strumwasser S,. Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci. 1991; 57: 73-79.
24. Strickland TL, Mena I, Villanueva-Meyer J, et al,. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci. 1993; 5: 419-427. (Pubitemid 23326593)
25. Beveridge TJ, Gill KE, Hanlon CA, et al,. Parallel studies of cocaine-related neural and cognitive impairment in humans and monkeys. Philos Trans R Soc Lond B Biol Sci. 2008; 363: 3257-3266.
26. Fernandez-Serrano MJ, Perez-Garcia M, Schmidt Rio-Valle J, et al,. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions [published online ahead of print Dec 9, 2009]. J Psychopharmacol. 2010; 24: 1317-1332.
27. Ludwig FC, Smoke ME,. The measurement of biological age. Exp Aging Res. 1980; 6: 497-522. (Pubitemid 11057090)
28. Lofwall MR, Schuster A, Strain EC,. Changing profile of abused substances by older persons entering treatment. J Nerv Ment Dis. 2008; 196: 898-905.
29. Lofwall MR, Brooner RK, Bigelow GE, et al,. Characteristics of older opioid maintenance patients. J Subst Abuse Treat. 2005; 28: 265-272. (Pubitemid 40592128)
30. Oslin D, Liberto JG, O'Brien J, et al,. Naltrexone as an adjunctive treatment for older patients with alcohol dependence. Am J Geriatr Psychiatry. 1997; 5: 324-332. (Pubitemid 27483912)
31. Beynon CM, Roe B, Duffy P, et al,. Self reported health status, and health service contact, of illicit drug users aged 50 and over: A qualitative interview study in Merseyside, United Kingdom. BMC Geriatr. 2009; 9:45.
32. Schlaerth KR, Splawn RG, Ong J, et al,. Change in the pattern of illegal drug use in an inner city population over 50: An observational study. J Addict Dis. 2004; 23: 95-107. (Pubitemid 38656244)
33. Substance Abuse and Mental Health Services Administration. Results from the 2008 National Survey on Drug Use and Health: National Findings. Rockville, MD: Office of Applied Studies; 2009. NSDUH Series H-36, HHS Publication No. SMA 09-4434. Available at:. Accessed July 16, 2010.
34. Sheehan DV, Lecrubier Y, Sheehan KH, et al,. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998; 59 (20): 22-33; quiz 4- 57. (Pubitemid 29001829)
35. Feher EP, Mahurin RK, Doody RS, et al,. Establishing the limits of the Mini-Mental State. Examination of 'subtests'. Arch Neurol. 1992; 49: 87-92.
36. Kessler RC, Adler L, Ames M, et al,. The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population. Psychol Med. 2005; 35: 245-256. (Pubitemid 40259916)
37. National Comorbidity Survey: Adult ADHD Self-Report Scales. 18-Question ADHD-ASRS Symptoms Checklist v1.1. Available at:. Accessed July 16, 2010.
38. Zanarini MC, Vujanovic AA, Parachini EA, et al,. A screening measure for BPD: The McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). J Personal Disord. 2003; 17: 568-573. (Pubitemid 38084411)
39. Cohen S, Kamarck T, Mermelstein R,. A global measure of perceived stress. J Health Soc Behav. 1983; 24: 385-396.
40. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn., Text Revision. Washington, DC: American Psychiatric Association; 2000.
41. Akerele E, Levin FR,. Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia. Am J Addict. 2007; 16: 260-268. (Pubitemid 47174581)
42. Levin FR, Mariani JJ, Secora A, et al,. Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A preliminary open trial. J Dual Diagn. 2009; 5: 41-56.
43. Rohsenow DJ, Sirota AD, Martin RA, et al,. The Cocaine Effects Questionnaire for patient populations: Development and psychometric properties. Addict Behav. 2004; 29: 537-553. (Pubitemid 38410836)
44. Wilkinson GS,. Wide Range Achievement Test 3. Wilmington, DE: Wide Range Inc.; 1993.
45. Folstein MF, Folstein SE, McHugh PR,. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189-198.
46. Wechsler DA,. Wechsler Adult Intelligence Scale, 3rd edn. San Antonio, TX: The Psychological Corporation; 1997.
47. Lezak MD, Howieson DB, Loring DW,. Orientation and attention. Neuropsychological Assessment, 4th edn. New York. NY: Oxford University Press; 2004: 351-360.
48. Bowie CR, Harvey PD,. Administration and interpretation of the Trail Making Test. Nat Protoc. 2006; 1: 2277-2281.
49. Shirts BH, Prasad KM, Pogue-Geile MF, et al,. Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia. Schizophr Res. 2008; 106: 268-274.
50. Jensen AR, Figueroa RA,. Forward and backward digit span interaction with race and IQ: Predictions from Jensen's theory. J Educ Psychol. 1975; 67: 882-893.
51. Woicik PA, Moeller SJ, Alia-Klein N, et al,. The neuropsychology of cocaine addiction: Recent cocaine use masks impairment. Neuropsychopharmacology. 2009; 34: 1112-1122.
52. Awtry EH, Philippides GJ,. Alcoholic and cocaine-associated cardiomyopathies. Prog Cardiovasc Dis. 2010; 52: 289-299.
53. Weintraub E, Dixon L, Delahanty J, et al,. Reason for medical hospitalization among adult alcohol and drug abusers. Am J Addict. 2001; 10: 167-177. (Pubitemid 32566028)
54. Herrero MJ, Domingo-Salvany A, Torrens M, et al,. Psychiatric comorbidity in young cocaine users: Induced versus independent disorders. Addiction. 2008; 103: 284-293.
55. Bartzokis G, Beckson M, Lu PH, et al,. Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: Implications for addiction research. Psychiatry Res. 2000; 98: 93-102. (Pubitemid 30179661)
56. Sim ME, Lyoo IK, Streeter CC, et al,. Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects. Neuropsychopharmacology. 2007; 32: 2229-2237. (Pubitemid 47417695)
57. Lyoo IK, Streeter CC, Ahn KH, et al,. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res. 2004; 131: 135-145. (Pubitemid 39094647)
58. Aharonovich E, Hasin DS, Brooks AC, et al,. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend. 2006; 81: 313-322. (Pubitemid 43152458)